Références (Page d'accueil):

1. Allergan. Juvederm VOLIFT DFU 72383JR12
2.Allergan. Juvederm Volbella DFU 72525JR11
3.Allergan. Juvederm Volite DFU DFU 2016;1: 1
4.Allergan. Voluma DFU Allergan 2016
5.Allergan. Juverderm ULTRA XC DFU 72360EC11 DFU 2012
6.Allergan. DFU Juvederm ULTRA PLUS 72351EC11C
7.Allergan. Juvederm Ultra Smile DFU 72349JR13
8.Allergan. Juvederm Ultra 2 DFU 72345JR14
9.Allergan. Juvederm Ultra 3 DFU 72490JR12
10.Allergan. Juvederm Ultra 4 DFU 72488JR12
13. DOF. Juvederm Properties DOF INT 0108 2015 2015;
11. Borelli C & Berneburg M. “Beauty lies in the eye of the beholder”? Aspects Journal of the German Society of Dermatology 2010;8: 326–330
12. Allergan. DATA ON FILE INT/0771/2016 Juvéderm® is the world’s leading HA brand N/A 2016
14. Hee. Rheological Properties and In Vivo Performance American Society for Dermatologic Surgery 2015;41: s73-s81
15. : Raspaldo H.. Volumizing effect of a new hyaluronic acid sub-dermal facial ¬ller: A retrospective analysis based on 102 cases Journal of Cosmet and Laser Ther 2008;10: 134-142
16. Philipp-Dormston WG et al.. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips Journal of Cosmetic Dermatology 2014;13: 125-134
17. Eccleston and Murphy. Juvéderm® Volbella in the perioral area: 12 month Dove Press Journal 2012;1: 1-6
18. Jones DJ, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study Dermatol Surg 2013;-: 1-11

Références (FAQ):

1. Allergan. Juvederm VOLIFT DFU 72383JR12
2.Allergan. Juvederm Volbella DFU 72525JR11
3.Allergan. Juvederm Volite DFU DFU 2016;1: 1
4.Allergan. Voluma DFU Allergan 2016
5.Allergan. Juverderm ULTRA XC DFU 72360EC11 DFU 2012
6.Allergan. DFU Juvederm ULTRA PLUS 72351EC11C
7.Allergan. Juvederm Ultra Smile DFU 72349JR13
8.Allergan. Juvederm Ultra 2 DFU 72345JR14
9.Allergan. Juvederm Ultra 3 DFU 72490JR12
10.Allergan. Juvederm Ultra 4 DFU 72488JR12
13. DOF. Juvederm Properties DOF INT 0108 2015 2015;
11. Borelli C & Berneburg M. “Beauty lies in the eye of the beholder”? Aspects Journal of the German Society of Dermatology 2010;8: 326–330
12. Allergan. DATA ON FILE INT/0771/2016 Juvéderm® is the world’s leading HA brand N/A 2016
14. Hee. Rheological Properties and In Vivo Performance American Society for Dermatologic Surgery 2015;41: s73-s81
15. : Raspaldo H.. Volumizing effect of a new hyaluronic acid sub-dermal facial ¬ller: A retrospective analysis based on 102 cases Journal of Cosmet and Laser Ther 2008;10: 134-142
16. Philipp-Dormston WG et al.. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips Journal of Cosmetic Dermatology 2014;13: 125-134
17. Eccleston and Murphy. Juvéderm® Volbella in the perioral area: 12 month Dove Press Journal 2012;1: 1-6
18. Jones DJ, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study Dermatol Surg 2013;-: 1-11
19.Frucht CS and Ortiz AE. Nonsurgical Cosmetic Procedures For Men: Trends And Technique Considerations J Clin Aesthet Dermatol. 2016;9: 33-43
21. Taieb M et al. Hyaluronic acid plus mannitol treatment for improved skin hydration and elasticity Journal of Cosmetic Dermatology 2012;11: 87-92
23.Hawkins SS et al. Cleansing, moisturizing, and sunprotection regimens for normal skin, self-perceived sensitive skin, and dermatologist-assessed sensitive skin Dermatologic Ther 2004;17: 63-68
24. Whitehead RD et al. You Are What You Eat: Within-Subject Increases in Fruit and Vegetable Consumption Confer Beneficial Skin-Color Changes Plos One 2012;7
25.Draelos ZK. Cosmetics: An Overview Curr Probl Dermatol 1995;7: 45-64
27. McCullough & Kelly (blank). Prevention and Treatment of Skin Aging Ann. N.Y. Acad. Sci 2006;1067: 323-331
28. Carruthers J et al. Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and CombinationT herapies–Consensus Recommendations Plastic and Reconstructive Surgery 2008;May Supplement Volume121, Number 5S
29.Brandt FS, Cazzaniga A. Hyaluronic acid gel fi llers in the management of facial aging Clinical Interventions in Aging 2008;3(1): 153-159

Références (Votre consultation):

1. Allergan. Juvederm VOLIFT DFU 72383JR12
2.Allergan. Juvederm Volbella DFU 72525JR11
3.Allergan. Juvederm Volite DFU DFU 2016;1: 1
4.Allergan. Voluma DFU Allergan 2016
5.Allergan. Juverderm ULTRA XC DFU 72360EC11 DFU 2012
6.Allergan. DFU Juvederm ULTRA PLUS 72351EC11C
7.Allergan. Juvederm Ultra Smile DFU 72349JR13
8.Allergan. Juvederm Ultra 2 DFU 72345JR14
9.Allergan. Juvederm Ultra 3 DFU 72490JR12
10.Allergan. Juvederm Ultra 4 DFU 72488JR12
13. DOF. Juvederm Properties DOF INT 0108 2015 2015;
11. Borelli C & Berneburg M. “Beauty lies in the eye of the beholder”? Aspects Journal of the German Society of Dermatology 2010;8: 326–330
13. DOF. Juvederm Properties DOF INT 0108 2015 2015;
11. Borelli C & Berneburg M. “Beauty lies in the eye of the beholder”? Aspects Journal of the German Society of Dermatology 2010;8: 326–330
12. Allergan. DATA ON FILE INT/0771/2016 Juvéderm® is the world’s leading HA brand N/A 2016
14. Hee. Rheological Properties and In Vivo Performance American Society for Dermatologic Surgery 2015;41: s73-s81
15. : Raspaldo H.. Volumizing effect of a new hyaluronic acid sub-dermal facial ¬ller: A retrospective analysis based on 102 cases Journal of Cosmet and Laser Ther 2008;10: 134-142
16. Philipp-Dormston WG et al.. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips Journal of Cosmetic Dermatology 2014;13: 125-134
17. Eccleston and Murphy. Juvéderm® Volbella in the perioral area: 12 month Dove Press Journal 2012;1: 1-6
18. Jones DJ, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study Dermatol Surg 2013;-: 1-11

Références (Juvederm® IT):

1. Allergan. Juvederm VOLIFT DFU 72383JR12
2.Allergan. Juvederm Volbella DFU 72525JR11
3.Allergan. Juvederm Volite DFU DFU 2016;1: 1
4.Allergan. Voluma DFU Allergan 2016
5.Allergan. Juverderm ULTRA XC DFU 72360EC11 DFU 2012
6.Allergan. DFU Juvederm ULTRA PLUS 72351EC11C
7.Allergan. Juvederm Ultra Smile DFU 72349JR13
8.Allergan. Juvederm Ultra 2 DFU 72345JR14
9.Allergan. Juvederm Ultra 3 DFU 72490JR12
10.Allergan. Juvederm Ultra 4 DFU 72488JR12
13. DOF. Juvederm Properties DOF INT 0108 2015 2015;
11. Borelli C & Berneburg M. “Beauty lies in the eye of the beholder”? Aspects Journal of the German Society of Dermatology 2010;8: 326–330
12. Allergan. DATA ON FILE INT/0771/2016 Juvéderm® is the world’s leading HA brand N/A 2016
14. Hee. Rheological Properties and In Vivo Performance American Society for Dermatologic Surgery 2015;41: s73-s81
15. : Raspaldo H.. Volumizing effect of a new hyaluronic acid sub-dermal facial ¬ller: A retrospective analysis based on 102 cases Journal of Cosmet and Laser Ther 2008;10: 134-142
17. Eccleston and Murphy. Juvéderm® Volbella in the perioral area: 12 month Dove Press Journal 2012;1: 1-6
18. Jones DJ, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study Dermatol Surg 2013;-: 1-11
19.Frucht CS and Ortiz AE. Nonsurgical Cosmetic Procedures For Men: Trends And Technique Considerations J Clin Aesthet Dermatol. 2016;9: 33-43
20.Monheit GD and Prather CL. Hyaluronic acid fillers for the male patient Dermatologic Ther 2007;20: 394-406
21. Taieb M et al. Hyaluronic acid plus mannitol treatment for improved skin hydration and elasticity Journal of Cosmetic Dermatology 2012;11: 87-92
25.Draelos ZK. Cosmetics: An Overview Curr Probl Dermatol 1995;7: 45-64
26.Coleman SR et al.. The Anatomy of the Aging Face: Volume Loss and Changes in 3-Dimensional Topography Aesthetic Surg J 2006;26(suppl): S4-S9
29.Brandt FS, Cazzaniga A. Hyaluronic acid gel fi llers in the management of facial aging Clinical Interventions in Aging 2008;3(1): 153-159